Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

BACKGROUND: Coagulopathies are a major class among COVID-19 associated complications. Although anticoagulants such as unfractionated Heparin and Enoxaparin are both being used for therapeutic mitigation of COVID associated coagulopathy (CAC), differences in their clinical outcomes remain to be inves...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EClinicalMedicine
Hauptverfasser: Pawlowski, Colin, Venkatakrishnan, AJ, Kirkup, Christian, Berner, Gabriela, Puranik, Arjun, O'Horo, John C., Badley, Andrew D., Soundararajan, Venky
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941023/
https://ncbi.nlm.nih.gov/pubmed/33718845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100774
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge